Dr. Sukhraj Dhami
Cell Line Development and Gene Therapy Scientist
During her doctoral training she physiology of T lymphocytes, developing experience in vector design, plasmid generation, AAV6 production in HEK, CRISPR, T cells isolation and CAR-T generation using both lentiviral and AAV-based methods. She has actively contributed her expertise to industrial projects for allogeneic CAR T cell engineering, collaborating with Citospin, a GMP-compliant company that manufactures human cell therapies. Julia brings her exceptional skill set to CONCEPT, accelerating advanced therapy research within our core facility.
Our lead team has experience across a range of disciplines and works closely with principal investigators from the wider NIBRT institute